MAR 27, 2015 3:06 PM PDT

Cane Toads Potentially Lucrative Export in Cancer Fight

WRITTEN BY: Ilene Schneider
Wait before you whack that toad. Not only is it frowned upon to kill cane toads inhumanely, but the amphibian's venom could be worth a bucket-load.

That's the message from The University of Queensland School of Pharmacy's Dr Harendra Parekh, who is exploring how cane toad venom can be used to fight cancer.

"People are killing cane toads by the millions for free, but it's potentially a very lucrative export market for Australia with the Chinese being extremely interested in naturally derived health products," Dr Parekh said.

"The Australian cane toad is very similar to the Asiatic toad, whose venom has been used in Chinese medicine for thousands of years.

"We already have several companies interested, as the Chinese value Australian toads because of the environment they enjoy here."

Dr Jing Jing, former PhD student at UQ discovered that cane toad poison could kill cancerous prostate cells while sparing healthy cells.

"However, before we can take it to market, we need to improve the venom's solubility (ability to dissolve) ? which we are well on the way to achieving," Dr Jing said.

"Investigating applications for other cancers is also firmly on our radar."

UQ has previously secured a seed grant from Hong Kong Polytechnic University in Shenzhen China for the work being conducted in Dr Parekh's group.

The research team hopes to begin validation in animals soon.

Cane toads were introduced to Queensland in 1935 to control the cane beetle, but quickly multiplied and were declared a pest.

They have since spread to the Northern Territory, Western Australia and New South Wales.

Source: University of Queensland
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUN 25, 2020
Cancer
Examining the Glioma Influenced Immune System
JUN 25, 2020
Examining the Glioma Influenced Immune System
The human body is a complicated network of systems and signals.  Many systems regulate themselves or others in vari ...
JUL 12, 2020
Cell & Molecular Biology
Lung Cancer is Different in Non-Smokers
JUL 12, 2020
Lung Cancer is Different in Non-Smokers
Not everyone that gets lung cancer is a current or former smoker, and researchers have now found that lung cancer is dif ...
JUL 13, 2020
Cancer
Breast cancer patients are 60% more likely to die of cancer after surviving a heart attack
JUL 13, 2020
Breast cancer patients are 60% more likely to die of cancer after surviving a heart attack
Unwelcome news from researchers at NYU Grossman School of Medicine suggests that breast cancer patients are 60% more lik ...
JUL 30, 2020
Cardiology
Protecting the Heart Against Cardiotoxicity
JUL 30, 2020
Protecting the Heart Against Cardiotoxicity
Doxorubicin is a potent chemotherapy drug used for many different cancers. Unfortunately, like all chemotherapies, doxor ...
AUG 03, 2020
Cancer
New research on fusion proteins that may help young patients with synovial sarcoma
AUG 03, 2020
New research on fusion proteins that may help young patients with synovial sarcoma
New research is published by scientists at Dana-Farber Cancer Institute have discovered new information that may help pa ...
AUG 10, 2020
Cancer
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
AUG 10, 2020
A New Prognostic Biomarker for Paclitaxel Sensitivity in Breast Cancer
Breast cancer is one of the deadliest cancers globally. It has been studied extensively with plenty of treatments availa ...
Loading Comments...